Relevant Links
Research in Medicine needs to ultimately translate into better treatment of patients. Researchers at the Nuffield Department of Medicine, University of Oxford, collaborate to develop better care and improved preventive measures. Findings in the laboratory are translated into changes in clinical practice, from Bench to Bedside.
# | Episode Title | Description | People | Date | |
---|---|---|---|---|---|
157 | Creative Commons | Social enterprisers and their role in addressing future challenges | Adopting a critical perspective, Dr Orsolya Ihasz outlines what makes social enterprisers valuable, and how could they contribute to the creation of important services and products to marginalised and disenfranchised communities. | Orsolya Ihasz | 08 Dec 2023 |
156 | Health Technology Assessment (HTA) in Resource-Constrained Settings: A Case Study of Ghana | Dr Brian Adu Asare discusses Health Technology Assessment (HTA) using Ghana as a case study. | Brian Adu Asare | 08 Dec 2023 | |
155 | Creative Commons | What kind of a problem is loneliness? Studying technology to understand policy concerns | This talk by Dr Gemma Hughes is intended to show how problems, such as loneliness, can be understood and researched in multiple ways. | Gemma Hughes | 08 Dec 2023 |
154 | Creative Commons | Molecular diagnosis and bacterial genotyping | Dr Janjira Thaipadungpanit from our MORU unit in Bangkok, Thailand, tells us about her research on molecular diagnosis and bacterial genotyping | Janjira Thaipadungpanit | 12 Apr 2017 |
153 | Creative Commons | Biomarkers for tropical diseases | Dr Markus Winterbert from our MORU unit in Bangkok, Thailand, tells us about his research on biomarkers for tropical diseases | Markus Winterberg | 12 Apr 2017 |
152 | Creative Commons | MORU Biosafety Level 3 and melioidosis in Thailand | Premjit Amornchai from our MORU unit in Bangkok, Thailand, tells us about her work as biosafety level 3 lab manager and microbioogy safety officer | Premjit Amornchai | 12 Apr 2017 |
151 | Creative Commons | Malaria control in Africa | Professor Bob Snow from our KEMRI-Wellcome programme in Nairobi, Kenya, tells us how his research brings together epidemiological profiles and government policies to maximise malaria control programmes in Africa | Bob Snow | 12 Apr 2017 |
150 | Creative Commons | Malaria elimination in the Greater Mekong sub-region | Dr Lorenz von Seidlein from our MORU unit in Bangkok, Thailand, tells us about his research on malaria elimination in the Greater Mekong sub-region | Lorenz von Seidlein | 12 Apr 2017 |
149 | Creative Commons | Tracking infections | Professor Derrick Crook from our Experimental Medicine division tells us about his research on tracking infections | Derek Crook | 10 Feb 2017 |
148 | Creative Commons | Mapping bacterial antibiotic resistance | Dr Olga Tosas-Auguet from our unit in Kenya tells us about her research on mapping bacterial antibiotic resistance | Olga Tosas-Auguet | 08 Feb 2017 |
147 | Creative Commons | Bacterial infections in Laos | David Dance from our LOMWRU unit in Laos tells us about his research on bacterial infections in Laos, particularly melioidosis | David Dance | 08 Feb 2017 |
146 | Creative Commons | Optimising malaria treatment | Dr Georgina Humphreys coordinates the WorldWide Antimalarial Resistance Network (WWARN) study groups by encouraging partner engagement and managing the data curation and development of publications. | Georgina Humphreys | 14 Dec 2016 |
145 | Creative Commons | Outbreak, the clinical research response | Dr Gail Carson is Head of ISARIC Coordinating Centre (International Severe Acute Respiratory and Emerging Infection Consortium), a network of networks established in 2011 to ensure a rapid research response to outbreaks of pandemic potential. | Gail Carson | 14 Dec 2016 |
144 | Creative Commons | Epigenetic modifications and cancer | Professor Skirmantas Kriaucionis aims to to elucidate the molecular function of DNA modifications in normal cells and cancer. | Skirmantas Kriaucionis | 14 Dec 2016 |
143 | Creative Commons | Fighting malaria in Myanmar | Professor Frank Smithuis is the director of MOCRU, Myanmar Oxford Clinical Research Unit. MOCRU involves a network of 6 clinics and 650 community health workers in remote areas. | Frank Smithuis | 14 Dec 2016 |
142 | Why we work on Alzheimer’s disease | Housed within the Target Discovery Institute, the Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI) juxtaposes drug discovery expertise alongside scientific and academic understanding of patients, disease mechanisms and model systems. | John Davis | 30 Nov 2016 | |
141 | Creative Commons | Gastrointestinal cancers | Dr Claire Palles studies whole genome sequencing data and targeted analyses with the aim of discovering genetic variants that affect susceptibility to colorectal cancer and Barrett’s oesophagus. | Claire Palles | 30 Nov 2016 |
140 | Creative Commons | Poor quality medicines | LOMWRU researchers conduct clinical research to help improve global, regional and Lao public health. They focus on infectious diseases, and also investigate diseases of nutrition and poverty. | Paul Newton | 30 Nov 2016 |
139 | Creative Commons | High altitude illness | Director of OUCRU-Nepal, Dr Buddha Basnyat studies high altitude illness as well as undifferentiated febrile illness in the tropics, both common but neglected problems in Nepal. | Buddha Basnyat | 02 Nov 2016 |
138 | Creative Commons | Infectious diseases in Indonesia | Professor Kevin Baird leads our Eijkman-Oxford Clinical Research Unit (EOCRU) in Jakarta, Indonesia. | Kevin Baird | 02 Nov 2016 |
137 | Creative Commons | Finding the best malaria treatments | Dr Mehul Dhorda heads the Asia Regional Centre of the WorldWide Antimalarial Resistance Network (WWARN). | Mehul Dhorda | 02 Nov 2016 |
136 | Creative Commons | Evolution and pathogenicity of viruses | Professor Peter Simmonds studies the epidemiology, evolution and emergence of a wide range of human pathogenic viruses. | Peter Simmonds | 02 Nov 2016 |
135 | Creative Commons | X-rays for drug discovery | Professor Frank von Delft works to ensure that X-ray structures can serve as a routine and predictive tool for generating novel chemistry for targeting proteins. | Frank von Delft | 23 Sep 2016 |
134 | Creative Commons | Modelling bacterial drug resistance | Professor Ben Cooper from MORU in Thailand uses mathematical modelling and statistical techniques to help understand the dynamics of infectious disease and evaluate potential control measures. | Ben Cooper | 01 Jul 2016 |
133 | Creative Commons | Epidemiology and malaria elimination | Dr Richard Maude's work combines clinical studies, descriptive epidemiology and mathematical modelling of malaria in South and Southeast Asia. | Richard Maude | 01 Jul 2016 |
132 | Creative Commons | Why data management matters | Naomi’s work focuses on supporting researchers to collect, clean and store research data. | Naomi Waithira | 02 Jun 2016 |
131 | Creative Commons | Malaria laboratory at MORU | Dr Kesinee Chotivanich's laboratory provides facilities and resources to researchers, students, and collaborators who are interested in tropical diseases, with the aim to improve patients’ care. | Kesinee Chotivanich | 02 Jun 2016 |
130 | Creative Commons | From information to structure | Dr Brian Marsden aims to make structural and chemical biology data accessible to non-experts, by providing computational resources including data management, sample tracking, in silico modelling support plus provision of public access to SGC data. | Brian Marsden | 02 Jun 2016 |
129 | Creative Commons | Repairing DNA damage | Dr Ross Chapman studies the molecular events triggered by DNA damage detection, and why defects in these events lead to immune deficiency and cancer in humans. | Ross Chapman | 28 Apr 2016 |
128 | Creative Commons | Malaria in Kenya | There is a great need for better treatments for malaria and for a preventative malaria vaccine. | Philip Bejon | 28 Apr 2016 |
127 | Creative Commons | Microbiology in the tropics | The Cambodia Oxford Medical Research Unit (COMRU) is based in Siem Reap, northern Cambodia, which remains one of the poorest countries in South East Asia with extremely limited health services. | Paul Turner | 28 Apr 2016 |
126 | Unravelling proteins | Dr Nicola Burgess-Brown heads the Biotechnology Group at the SGC, which generates proteins suitable for structural and functional studies. | Nicola Burgess-Brown | 28 Apr 2016 | |
125 | Targeting drug discovery | The development of new medicines is dependent on the identification of novel drug targets. | Kilian Huber | 28 Apr 2016 | |
124 | Creative Commons | Microbiology research in SE Asia | Dr Direk Limmathurotsakul's research focuses on the epidemiology of melioidosis, a bacterial infection caused by Burkholderia pseudomallei. | Direk Limmathurotsakul | 28 Apr 2016 |
123 | Creative Commons | Tropical neonatology | Dr Claudia Turner heads the clinical research program at the Cambodia Oxford Medical Research Unit (COMRU), in collaboration with the Angkor Hospital for Children. | Claudia Turner | 28 Apr 2016 |
122 | Creative Commons | Global health informatics | Dr Chris Paton studies the use of open-source Electronic Health Records (EHR) software, online learning and mobile technology to improve healthcare delivery in low-resource settings. | Chris Paton | 28 Apr 2016 |
121 | Creative Commons | Dengue diagnosis and management | With 390 million infections occuring each year, dengue is the most important mosquito-borne viral infection, and no vaccine is currently available. | Bridget Wills | 28 Apr 2016 |
120 | Understanding growth signals | Growth hormones and cytokines regulate the key physiological processes of growth and differentiation as well as responses to injury and infection. | Alex Bullock | 28 Apr 2016 | |
119 | Malaria in pregnancy | In pregnant women, severe malaria is responsible for high maternal mortality, and uncomplicated malaria results in in high morbidity. | Rose McGready | 04 Feb 2016 | |
118 | Reducing HIV | Men who have sex with men (MSM) are a stigmatised group in Africa, but a predominant actor in the transmission of HIV. | Eduard Sanders | 04 Feb 2016 | |
117 | Creative Commons | Cleaning up misfolded proteins | Misfolded proteins can either create the loss of a cellular function, or escape degradation, causing aggregation diseases. | John Christianson | 04 Feb 2016 |
116 | Creative Commons | Rare neurological disorders | Chorea-Acanthocytosis: ChAc is a rare progressive neurological disorder caused by mutations in a very complex gene. | Antonio Velayos-Baeza | 04 Feb 2016 |
115 | Creative Commons | Targeting cancer mechanisms | Professor Robert Gilbert's research focuses on the molecular mechanisms underlying membrane pore formation and cell adhesion. | Robert Gilbert | 07 Jan 2016 |
114 | Inflammation in disease | The main aim of Dr Xue's research is to understand the molecular and cellular mechanisms mediating inflammatory diseases, and to translate their findings into therapeutic concepts to treat these diseases. | Luzheng Xue | 07 Jan 2016 | |
113 | Creative Commons | Computation and genetics | Resistance to drugs in bacteria can be aquired by swapping genes between individual bacteria. Computer programs developed by Dr Iqbal enable doctors to predict which antibiotics will be met with drug resistance, enabling the selection of the right drug. | Zamin Iqbal | 07 Jan 2016 |
112 | Creative Commons | The Evolution of the Genome | Computational and stastistical methods help us understand evolution as well as genetic disease. | Gerton Lunter | 02 Dec 2015 |
111 | Tropical Immunology | Melioidosis is a neglected tropical disease, and a major infectious killer in South East Asia. Melioidosis particularly affects people with diabetes. | Susanna Dunachie | 02 Dec 2015 | |
110 | Sharing data to fight malaria | Over 250 Institutions participate in the effort of sharing data on the efficacy of antimalarial drugs, which involves standardising and re-analysing data. | Philippe Guérin | 02 Dec 2015 | |
109 | Creative Commons | Artemisinin Resistance | Artemisinins are very poweful tools in the treatment of malaria, and the emerging loss of their activity has the potential to create a major public health problem. | Charlie Woodrow | 05 Oct 2015 |
108 | Creative Commons | The ethics of research | Identifying and addressing ethical issues are key to the success of any clinical trials, particularly when working with vulnerable populations. | Phaik Yeong Cheah | 05 Oct 2015 |
107 | Creative Commons | Science and Society | In settings with high level of poverty and over-stretched health services, researchers have even greater responsibilities to the communities and study participants. | Vicki Marsh | 05 Oct 2015 |
106 | Creative Commons | Melanoma | Melanoma or skin cancer is one of the fastest rising cancer types. When identified early, melanoma is relatively easy to cure, but once it starts to metastasise, it becomes very difficult to treat. | Colin Goding | 05 Oct 2015 |
105 | Creative Commons | Targeting epigenetics to treat cancer | Transcription is a tightly regulated process, where chemical modifications initiate the duplication of genetic material. This epigenetic process is often dysregulated in cancer, but it can be targeted with small molecule inhibitors. | Panagis Filippakopoulos | 05 Oct 2015 |
104 | Creative Commons | A deep breath in | Asthma and COPD (chronic obstructive pulmonary disease) are common conditions that affect the lives of many people. | Mona Bafadhel | 28 Jul 2015 |
103 | Creative Commons | Chemistry, epigenetics and drugs | Alteration of gene expression is fundamental to many diseases. A better understanding of how epigenetic proteins affect diseases provides a starting point for therapy development and the discovery of new drug. | Paul Brennan | 28 Jul 2015 |
102 | Creative Commons | The genetics of metabolic diseases | A missing step in a metabolic pathway leads to the build-up of toxic compounds, and the lack of materials essential for normal function. | Wyatt Yue | 28 Jul 2015 |
101 | Creative Commons | The economics of tropical diseases | Economics and health are interlinked in many ways, as seen in the vicious cycle between poverty and ill health. | Yoel Lubell | 28 Jul 2015 |
100 | Creative Commons | Getting the dose right | Too high a dose can result in toxicity and side-effects, too low a dose can cause the illness to come back and at worse develop resistance. | Joel Tarning | 28 Jul 2015 |
99 | Creative Commons | Enteric fever | Dr Christiane Dolecek speaks about the research on enteric fever she conducted in Vietman and Nepal. | Christiane Dolecek | 20 May 2015 |
98 | Creative Commons | Emerging Infectious Diseases | Professor Peter Horby is Senior Clinical Research Fellow. His research focusses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. | Peter Horby | 11 Mar 2015 |
97 | Creative Commons | Human Cancer Genetics | Dr Gareth Bond, Associate Member of the Ludwig Institute for Cancer Research, studies the influence of genetic variants on the origins, progression and treatment of human cancer. | Gareth Bond | 11 Mar 2015 |
96 | Creative Commons | Personalised Medicine | Dr Jenny Taylor is the Programme Director for the Genomic Medicine Theme, Wellcome Trust Centre for Human Genetics. Her research bridges the gap between genetics research and the use of its discoveries in diagnosis or treatment of medical conditions. | Jenny Taylor | 09 Feb 2015 |
95 | Creative Commons | Cancer predisposition and evolution | Identifying genes that increase the risk of bowel or other cancers allows us to offer preventative measures, such as removing tumours at an early stage. A better understanding of how and why cancers grow also helps develop improved treatments. | Ian Tomlinson | 09 Feb 2015 |
94 | Creative Commons | Cancer Informatics | Cancer research now generates huge amounts of data, and sophisticated computational tools are needed to answer biological questions. Making sense of this variability at molecular level will help us better tailor treatments to individual cancer patients. | Benjamin Schuster-Böckler | 09 Feb 2015 |
93 | Biological imaging | Video microscopy aims to improve target discovery and drug development and to do so generates large volumes of data. | Jens Rittscher | 09 Feb 2015 | |
92 | Pharmacogenomics | Dr Sebastian Nijman develops new approaches to study signalling networks in cancer cells and uncover specific weaknesses, particularly in breast and lung cancer. This can be used to develop more effective drugs and to better guide treatment decisions. | Sebastian Nijman | 09 Feb 2015 | |
91 | Creative Commons | Microbiology in Thailand | Microbiology in Thailand | Stuart Blacksell | 10 Dec 2014 |
90 | Creative Commons | Infectious diseases in South East Asia | Infectious diseases in South East Asia | Nick Day | 10 Dec 2014 |
89 | Creative Commons | Rickettsial Disease | Daniel Paris: Rickettsial Disease | Daniel Paris | 10 Dec 2014 |
88 | Creative Commons | Better hospitals for children | Oxford Health Systems Research Collaboration (OHSCAR) | Mike English | 10 Dec 2014 |
87 | Creative Commons | Health systems research | Governance in practice | Sassy Molyneux | 10 Dec 2014 |
86 | Virus entry | Novel light microscopy techniques allow us to track single viruses. | Sergi Padilla-Parra | 10 Dec 2014 | |
85 | Creative Commons | DNA replication and Cancer | DNA replication and Cancer | Catherine Green | 10 Dec 2014 |
84 | Creative Commons | Big Data | Over the past decade, data-driven science has produced enormous sets of data. | Christopher Yau | 10 Dec 2014 |
83 | Between research and humanitarian | Between research and humanitarian | Francois Nosten | 10 Dec 2014 | |
82 | Creative Commons | Tuberculous Meningitis | Tuberculous Meningitis | Guy Thwaites | 07 Oct 2014 |
81 | Creative Commons | Crohn's disease | Innate immune system | Alison Simmons | 07 Oct 2014 |
80 | Structural biology and vaccines | Structure of viruses | Dave Stuart | 07 Oct 2014 | |
79 | Creative Commons | Stem cells and cancer | Adult gastrointestinal stem cells | Simon Leedham | 07 Oct 2014 |
78 | Creative Commons | Cancer and innate immunity | Inflammatory signalling | Mads Gryd-Hansen | 07 Oct 2014 |
77 | Asthma | Airway inflammation | Ian Pavord | 07 Oct 2014 | |
76 | Creative Commons | Pneumococcal diseases | Genetics and genomics of Streptococcus pneumoniae | Angela Brueggemann | 07 Oct 2014 |
75 | Creative Commons | Active and passive immunity to Influenza | Professor Townsend tells us about lessons to be drawn from the history of immunology in Oxford, from 1979 onwards, until his current research on active and passive immunity to influenza. | Alain Townsend | 01 Oct 2013 |
74 | Creative Commons | Human Genetics | Professor Peter Donnelly tells us how genetics helps us to understand common diseases and develop new drugs. | Peter Donnelly | 09 Jul 2013 |
73 | Creative Commons | The Global Health Network | Dr Trudie Lang tells us how the Global Health Network facilitates collaboration and resource sharing. | Trudie Lang | 26 Jun 2013 |
72 | Creative Commons | Artemisinin therapy for malaria by Professor Nick White | Professor Nick White talks about the future of artemisinin and other drug therapies for malaria. | Nick White | 18 Jun 2013 |
71 | Creative Commons | Atherosclerosis and immunity by Professor Chris O'Callaghan | Professor Chris O'Callaghan tells us about the role of our immune system in vascular disease. | Chris O’Callaghan | 11 Jun 2013 |
70 | Respiratory Medicine | Dr Najib Rahman talks about his research on respiratory medicine. | Najib Rahman | 28 May 2013 | |
69 | Creative Commons | Psychiatric genetics | Professor Jonathan Flint talks about his research on psychiatric genetics. | Jonathan Flint | 21 May 2013 |
68 | Creative Commons | Development of chemical probes | Professor Stefan Knapp tells us how the development of chemical probes helps us to find new drugs. | Stefan Knapp | 21 May 2013 |
67 | Can we block malaria transmission | Dr Sumi Biswas talks about the development of a vaccine aimed at the mosquito stage of the malaria parasite cycle. | Sumi Biswas | 07 May 2013 | |
66 | Creative Commons | Membrane proteins and drug development | Dr Liz Carpenter talks about her research on membrane proteins and drug development. | Liz Carpenter | 29 Apr 2013 |
65 | Creative Commons | MedicineAfrica | Dr Alexander Finlayson tells us how MedicineAfrica aims to bring healthcare professionals around the world in a global expert network. | Alexander Finlayson | 29 Apr 2013 |
64 | Creative Commons | Structural cell biology of virus infection | Professor Kay Grunewald tells us how structural cell biology can help us understand virus infection. | Kay Grunewald | 29 Apr 2013 |
63 | Molecular immunology | Dr Christian Eggeling tells us how new imaging methods help us understand immunology at the molecular level. | Christian Eggeling | 29 Apr 2013 | |
62 | Creative Commons | The lymphatic system in immunity and cancer | Professor David Jackson tells us about the role of the lymphatic system in immunity and cancer. | David Jackson | 29 Apr 2013 |
61 | Cutaneous immunology | Professor Graham Ogg talks about the role of our skin as a barrier against infection. | Graham Ogg | 29 Apr 2013 | |
60 | Creative Commons | Fiona Powrie | Professor Fiona Powrie talks about the importance of our guts, and her research in gastroenterology. | Fiona Powrie | 29 Apr 2013 |
59 | Creative Commons | Clinical Trials in Gastroenterology | Dr Simon Travis tells us how clinical trials bring tomorrows treatments to patients today. | Simon Travis | 25 Mar 2013 |
58 | Creative Commons | Cancer Immunlogy | Professor Vincenzo Cerundolo tells us how research in immunology leads to the development of new cancer treatments. | Vincenzo Cerundolo | 25 Mar 2013 |
- 1 of 2
- next ›